( p = 0.6654). In contrast to 5-hmC, 5-mC staining showed no significant changes between the 3 groups. Univariate analysis revealed no significant association between patients' characteristics, disease severity, and the levels of 5-mC and 5-hmC. Conclusion: Our findings indicate that imbalances in DNA hydroxymethylation may play a role in the pathogenesis of HS rather than DNA methylation. Further studies are warranted to investigate the significance of DNA hydroxymethylation and the regulating enzymes in HS in order to advance our knowledge of the inflammatory network in this disease.
Up to 40% of patients with HS report a familial occurrence [5] . Therefore, genes predisposing to HS are under intense investigation. Predominantly loss-of-function mutations have been reported in genes encoding the γ-secretase transmembrane complex, namely presenilin-1, presenilin enhancer-2, and nicastrin [6] [7] [8] . γ-Secretase is a protease complex mediating cleavage of the integral membrane protein Notch, which is involved in normal hair follicle development [9] . γ-Secretasedeficient mice with dysregulated Notch signaling pathways showed skin alterations that are histopathologically similar to those observed in HS patients [10] . However, the reported mutations are found only in a minority of HS patients. Therefore, it must be assumed that further biological pathways may influence this skin condition which shows a wide variability in clinical phenotypes. Apart from variations in the genetic code, epigenetic modifications can also influence gene expression and may cause differences in phenotype and the immune system [11, 12] .
DNA methylation is one of the more studied epigenetic modifications and can be influenced by environmental factors [13] . Several DNA methyltransferases (DNMTs) are responsible for de novo methylation by transferring a methyl group to the fifth position of the cytosine which results in methylation (5-methylcytosine, 5-mC) [14] . 5-mC is further hydroxylated to 5-hydroxymethylcytosine (5-hmC), a process catalyzed by ten-eleven translocation (TET) proteins in association with isocitrate dehydrogenases (IDHs). Together with 5-formylcytosine and 5-carboxylcytosine, 5-hmC is an essential intermediate in the DNA demethylation process [15] .
Imbalances in DNA methylation can lead to genome destabilization and deregulation of genes, and have been described to play a role in inflammatory diseases (e.g., ulcerative colitis, lichen sclerosis, and psoriasis) and many cancer types [11, [16] [17] [18] .
However, to the best of our knowledge, global DNA methylation and hydroxymethylation have not been studied in HS. Therefore, we conducted this study to investigate the global methylation and hydroxymethylation status in HS patients and healthy controls.
Materials and Methods
For further details, see the supplementary material (for all online suppl. material, see www.karger.com/10.1159/000478043) [19, 20] ( Fig. 1 ) .
Results
With regard to levels of 5-mC, there was no significant difference between the 3 groups ( Fig. 2 ) . However, 5-hmC levels were significantly lower in healthy-appearing peri- ( Fig. 3 ). There was no significant difference between lesional HS skin and perilesional HS skin regarding 5-hmC levels ( p = 0.6654). The obtained mean H-scores for 5-mC and 5-hmC in the 3 groups are shown in detail in Table 1 . Next, we examined whether the content of 5-mC and 5-hmC in healthy controls and perilesional and lesional HS skin was influenced by patients' characteristics (i.e., age, gender, body mass index, and smoking status) and by disease severity, as assessed by the Hurley classification system and the modified Hidradenitis Suppurativa Score (mHSS). Univariate analysis revealed no significant association between the analyzed variables and the levels of 5-mC and 5-hmC ( Table 2 ).
Discussion
The imbalance between methylation and demethylation is well described in cancer, but it has also emerged as an important epigenetic modification in the development of inflammatory skin diseases [11, 16, 17] . However, to date, there are no reports concerning patients with HS.
Our results showed no difference in the global DNA methylation, as measured by the level of 5-mC, in lesional and perilesional HS skin compared to healthy controls.
Recently, emerging evidence has focused on the role of 5-hmC, a 5-mC oxidation derivate catalyzed by TET proteins. Our findings indicated significantly lower levels of 5-hmC in perilesional and lesional HS skin compared to 
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Color version available online healthy controls ( Fig. 3 ) . However, there was no significant difference between lesional and perilesional HS skin regarding 5-hmC levels. Generation of 5-mC is mainly regulated by the function of DNMT proteins, and 5-mC is a precursor of 5-hmC in the process of DNA demethylation. The conversion of 5-mC to 5-hmC is catalyzed by the TET enzymes in association with IDHs [21] . Reportedly, 5-hmC homeostasis is largely influenced by 5-mC levels, which, in turn, would suggest that the loss of 5-hmC is accompanied by a loss or accumulation of its precursor 5-mC [21] . However, while we could show a significant reduction of the 5-hmC levels in lesional and perilesional HS skin compared to healthy controls, we did not observe any change of the global 5-mC levels. Thus, our data suggest that 5-hmC homeostasis is dynamic and an independent epigenetic marker. Accordingly, other studies showed that, beyond being a transient intermediate, 5-hmC is directly involved in the regulation of gene expression and transcription [22] [23] [24] . Decreased global levels of 5-hmC and unchanged 5-mC levels were observed in multiple cancers, including colon, prostate, and breast cancers [25] . In melanoma, loss of 5-hmC was observed compared to benign nevi, whereas the global levels of 5-mC showed no significant differences [22] .
In contrast, in human osteoarthritic chondrocytes, 5-hmC levels were increased compared to normal chondrocytes, while the 5-mC levels did not differ significantly [26] .
Aberrant 5-hydroxymethylation has also been observed in chronic inflammatory conditions. Studies showed that inflammatory cytokines regulate 5-hmC levels in an inflammatory microenvironment [26, 27] . In primary human chondrocytes and in monocytes, stimulation with proinflammatory interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) suppressed the global levels of 5-hmC by inhibiting the activity of the TET and IDH enzymes. Interestingly, there was a decrease in 5-hydroxymethylation near the transcription starting sites of several specific genes that are known to be upregulated by IL-1β and TNF-α [27] . In HS skin, the reduction of 5-hmC levels can also be a consequence of the complex inflammatory network present in HS, in which the increased expression of IL-1β and TNF-α, among other cytokines, has been well described. Therefore, our data indicate a link between the inflammatory microenvironment in HS and the epigenome [28] [29] [30] .
A study published in 2014 by Calabrese et al. [18] evaluated TET2 gene expression and 5-hmC level in peripheral blood mononuclear cells from patients with multiple sclerosis. Comparable to our data, their results showed decreased levels of 5-hmC and TET2. The authors concluded that the observed decrease of the TET2 enzyme and 5-hmC level may play a role in the inflammatory pathogenesis of multiple sclerosis [18] .
Looking for the cause of diminished 5-hmC levels but normal 5-mC levels, focus was placed on the function and expression of the TET proteins. Studies showed an association between decreased activity of TET proteins and loss of 5-hmC [18, 22, 27] . In melanoma, for example, restoring TET2 or IDH2 function significantly suppressed tumor growth in animal models and restored the 5-hmC epigenome [22] .
The TET proteins do not only mediate the generation of 5-hmC, but also play an important role in the transcription regulation. Their role in inflammation and immunity has already been investigated. It could be shown that TET2 repressed the transcription of the proinflammatory IL-6, and the loss of TET2 resulted in the upregulation of several inflammatory mediators. TET2-deficient mice showed a more severe inflammatory phenotype with increased levels of IL-6 and increased infiltration of inflammatory cells [31] . Given our data and due to the known inflammatory pathogenesis of HS, it will, therefore, be of great interest to investigate the expression and function of these proteins in HS in future studies.
Besides DNA methylation, microRNA (miRNA)-mediated RNA interference also belongs to the group of epigenetic nucleotide modifications [17] . miRNAs represent another level of 5-hmC regulation. Overexpression of miRNAs (e.g., miR-125, miR-202, and miR-29), resulted in repression of TET proteins and decreased levels of 5-hmC [32, 33] . We, in turn, could recently demonstrate a significant association between altered expression levels of the key regulators of the miRNA biogenesis and inflammatory HS lesions [34] .
The difference in mean age and number of current smokers between the healthy controls and the HS groups in the present study and its potential influence on (hydroxy)methylation, among other factors, needs to be addressed. For this purpose, we conducted a univariate analysis with the clinical parameters of age, gender, body mass index, and smoking status to assess for potential effects on 5-mC and 5-hmC levels and found no significant associations. Specifically, no association with smoking could be found, in line with previous reports which have shown that DNA methylation of only a few distinct gene regions is influenced by smoking rather than global methylation [35] . In contrast, data on ageassociated changes of global DNA methylation could not be found in our study, although accumulating literature shows increased hypomethylation with age, most likely due to decreased DNMT activity in elderly patients [36] . Nevertheless, results cannot be generalized because changes in methylation levels have been reported to be tissue specific [37] . There was no difference between patients in Hurley stage II and III regarding 5-mC and 5-hmC levels. As we only included patients with Hurley stage II and III, we also included the mHSS, which represents a more precise HS severity score, thus allowing a more detailed subdivision of HS patients with regard to disease severity [3] . Similarly, we observed no significant correlation between the mHSS and levels of 5-mC and 5-hmC.
In this pilot study, we have shown that epigenetic modifications, particularly the significant reduction of global 5-hydroxymethylation, are present in patients with HS. However, our study could not determine by which mechanisms 5-hmC levels are altered. Thus, further investigating the role of DNA hydroxymethylation and the Univariate association between patient characteristics and global 5-mC and 5-hmC expression as assessed by the H-score in healthy controls (HC) and perilesional (PeriLS) and lesional (LS) hidradenitis suppurativa skin 
